Medical devices, healthcare technology and the business of care
510(k) clearance · K262963

TMC Implant Fixation System

Treace Medical Concepts, Inc. · Decision date Sep 15, 2026

MEDTECHLEDGER EXPLANATIONK262963

What did the FDA decide?

Treace Medical Concepts, Inc. received FDA clearance for the TMC Implant Fixation System under K262963, a Special 510(k) premarket notification. The September 15, 2026 decision letter records a substantially equivalent determination, which permits marketing under general controls rather than constituting PMA approval. The submission was dated August 24, 2026 and received August 25, 2026, with the summary dated September 9, 2026. The device is a Class II bone fixation system under 21 CFR 888.3030, with primary product code HRS and subsequent codes JDR and HWC.

The system comprises straight, L-shaped, H-shaped, anatomically curved and intramedullary plates, cannulated and non-cannulated compression implants, and associated instruments, plus 2.5, 2.7, 3.0 and 3.3 mm locking and non-locking screws in 10–36 mm lengths, all of Ti6Al4V-ELI titanium alloy and gamma-irradiated sterile. The primary predicate is the same-named system cleared as K251135 on August 21, 2025; additional predicates are the Wright PROSTEP TBI System (K190970). The summary states the changes do not affect reprocessing, biocompatibility or sterility, and reports mechanical construct testing to ASTM F382 and F543. The specific changed item is not identified in the available excerpts.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 15, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262963
Regulatory pathway
510(k) premarket notification
Product code
HRS
Decision code
SESE
Decision date
Sep 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Product code
HRS
FDA device class
2

FDA decision timeline

  1. K262963 received

    Application receipt date recorded by FDA.

  2. K262963 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
ARTHREX, INC.510(k) clearanceOct 29, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceOct 23, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Treace Medical Concepts, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ponte Vedra, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records